|
7-hydroxyindole |
|
Pseudomonas |
Biofilm |
Preclinical (in vivo) |
Lee J, et al. 2009. Microb Biotechnol |
|
Indole |
Depiction based on curated SMILES
N
H
|
Pseudomonas |
Biofilm |
Preclinical (in vivo) |
Lee J, et al. 2009. Microb Biotechnol |
|
3-(6,6-dimethyl-3-oxotetrahydro-2H-pyran-2-yl)-3-hydroxy-1,3-dihydro-2H-indol-2-one |
Depiction based on curated SMILES
O
N
H
O
CH
3
OH
O
CH
3
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
von Ambüren J, et al. 2020. Microorganisms |
|
3-hydroxy-3-[2-oxo-2-(pyridin-4-yl)ethyl]-1,3-dihydro-2H-indol-2-one |
Depiction based on curated SMILES
OH
N
O
HN
O
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
von Ambüren J, et al. 2020. Microorganisms |
|
1H-Indole, 3-(2-pyridin-4-yl-thiazol-4-yl)- |
Depiction based on curated SMILES
N
N
S
HN
|
Pseudomonas Yersinia |
TTSS (Type III secretion system) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) |
Harmon DE, et al. 2010. Antimicrob Agents Chemother
|
|
Norharmane |
Depiction based on curated SMILES
N
H
N
|
Escherichia Pseudomonas |
Biofilm Biofilm |
Preclinical (in vivo) Preclinical (in vitro) |
Lee JH, et al. 2017. Phytomedicine
|
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |